Honorary Editor-in-Chief: Prof. Qimin Zhan, MD, PhD

Prof. Qimin Zhan has received Changjiang Scholarship of Ministry of Education. He is also a winner of the National Science Foundation for Distinguished Young Scholars and the national candidate of New Century Talent Project. He’s a chief expert of Innovation Group of the National Natural Science Foundation of China, and a Chief scientist of the National Program on Key Basic Research Project of China (973 Program). He has been awarded Honorary Professorship at Kings College and University of Manchester, Visiting Professorship at Juntendo University and Keio University.

He currently serves as Chairman of Chinese Society of Microcirculation, Vice President of Chinese Medical Doctor Association, Vice President of China International Exchange and Promotive Association for Medical and Health Care, and Chairman of the Overseas Physicians division of the Western Returned Scholars Association.

He has been engaged in the research of molecular oncology and translational medicine for a long time. He made outstanding achievements in the field of molecular oncology, including the first demonstrations in tumor suppressor p53-regulated signaling pathways in the cell cycle checkpoints and genomic stability following genotoxic stress. He also made the first demonstration of genomic alterations in human esophageal squamous cell carcinoma (ESCC), defining significant mutated genes, copy number variations and structure veriations during the ESCC development. He has published more than 300 peer-reviewed papers and 13 books in international journals of medical biology. He has been invited as keynote speakers of national and international conferences for over 200 times and served as co-chairman of 15 international academic conferences.

Editor-in-Chief: Prof. Yang Ke, MD, PhD

  Member of the National Academy of Medicine of the U.S. National Academies

  Former Executive Vice President of Peking University and Peking University Health Science Center

  Former Director of the Laboratory of Genetics at Peking University Cancer Hospital

Prof. Ke’s research focuses on the etiology and mechanisms of upper gastrointestinal malignancies, precision prevention strategies for populations, and the translation and application of health-related big data. Her team has established population-based cohorts in high-incidence regions for esophageal cancer in China to investigate etiology and evaluate the effectiveness and health economics of early screening for the disease. She has led key national research projects, including the 863 and 973 High-Tech Programs, National Natural Science Foundation (major and general projects), and major scientific initiatives under the Ministry of Science and Technology and the National Health Commission. Prof. Ke has published over 100 peer-reviewed publications both in Chinese and English in leading journals, and her work has been cited for more than 1,000 times. Her systematic research achievements have been published in top-tier journals across multiple professional fields, including The Lancet, Journal of Clinical Oncology, Gut, Cell Reports Medicine, Annals of Surgery, Cancer Research, and Clinical Gastroenterology and Hepatology, covering gastroenterology, oncology, epidemiology, infectious diseases, surgery, endoscopy, and pathology.

Scientific-professional societies

Prof. Ke currently serves as:

Rotating President of the Beijing Cancer Prevention and Treatment Society

President of the Peking University Health Science Center Alumni Association

Additionally, she has held positions:

Member of the 11th and 12th National Committee of the Chinese People’s Political Consultative Conference (CPPCC)

Chairperson of the Working Committee for Graduate Medical and Pharmaceutical Education of the Office of Academic Degrees of the State Council

Chairperson of the Health Professional Education Committee of the Chinese Association of Higher Education

Vice President of the Chinese Medical Association

Vice Chairperson of the Chinese Anti-Cancer Association

Executive Editor-in-Chief: Prof. Jiafu Ji, MD, PhD, DrPH, FRCS

  Academician of the Chinese Academy of Engineering

  Director, Peking University Cancer Research Center

  Professor & Director of the Surgical Department, Peking University Cancer Hospital

Prof. Jiafu Ji is a world-renowned surgeon and scientist specializing in gastrointestinal oncology. He is an experienced healthcare administrator and a leading figure in cancer prevention and control. His team has pioneered studies related to D2 lymphadenectomy, laparoscopic gastrectomy, perioperative neoadjuvant therapy, and precision diagnosis with AI. These studies have been successfully translated into clinical practice advancements, significantly improving patient survival rates and quality of life in China and globally. Prof. Ji is dedicated to the standardization of gastrectomy, and his training programs have benefited over ten thousand surgeons in China. He was the first Chinese president of the International Gastric Cancer Association, where he worked to promote equity in gastric cancer treatment worldwide, particularly in less developed countries and regions. He is at the forefront of constructing the largest gastric cancer biobank and clinical database in China, implementing innovative analytical and computational tools to enhance monitoring, collaborative research, and patient care. Prof. Ji has published more than 400 research papers as the first or corresponding author, including over 300 in SCI journals (H-index 76) such as Cell, JAMA, Lancet, Lancet Oncology, and Science Translational Medicine, and has obtained 30 patents. His team won the second prize of the National Science and Technology Progress Award (2017) of China for their outstanding contributions to gastric cancer prevention and control.

Awards and honors

Guanghua Engineering Science and Techology Prize (2024)

China Medical Science and Technology Award, First Class (2024, 2016)

Ho Leung Ho Lee Foundation Prize for Scientific and Technological Progress (2020)

Sino Phil Asia International Peace Prize (2019)

Study UK Alumni Awards - Professional Achievement Award (2018)

Adjunct Professor, Johns Hopkins University, USA (2018)

Visiting Professor, University of Tennessee Health Science Center, USA (2018)

National Science and Technology Progress Award, Second Class (2017)

“Beijing Scholar” (Beijing Municipal High-level Talent Cultivation Plan) (2017)

Outstanding Achievement Award for Scientific Research in Colleges and Universities (Science and Technology Advancement Award) of the Ministry of Education of the People’s Republic of China, First Class (2016)

WuXi PharmaTech Life Science and Chemistry Awards - Outstanding Achievements Award (2015)

Wu Jieping-Paul Janssen Medical and Pharmaceutical Award (2014)

Honorary Distinguished Professor, Cardiff University, UK (2013)

Scientific-professional societies

Chinese Society of Surgery (Vice President, 2025-present)

Beijing Anti-Cancer Association (BACA, President, 2018-present)

Royal College of Surgeons of England (RCS, Fellow, 2017-present)

China International Exchange and Promotive Association for Medical and Health Care (Vice President, 2015-present)

International Gastric Cancer Association (Council Member, 2007-present)

International Gastric Cancer Association (President, 2017-2019)

Chinese Anti-Cancer Association (CACA, Vice President, 2017-2022)

Chinese Gastric Cancer Association (CGCA, President, 2010-2017)

Chinese Medical Association (CMA, Executive Council Member, 2015-2022)